MENU
+Compare
SMTI
Stock ticker: NASDAQ
AS OF
Nov 26 closing price
Price
$20.76
Change
+$0.39 (+1.91%)
Capitalization
186.76M

SMTI Sanara MedTech Forecast, Technical & Fundamental Analysis

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets... Show more

SMTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SMTI with price predictions
Nov 26, 2025

SMTI's Stochastic Oscillator is staying in oversold zone for 10 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SMTI's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SMTI advanced for three days, in of 256 cases, the price rose further within the following month. The odds of a continued upward trend are .

SMTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SMTI as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SMTI turned negative on October 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for SMTI moved below the 200-day moving average on November 14, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SMTI entered a downward trend on November 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (30.211) is normal, around the industry mean (9.206). P/E Ratio (0.000) is within average values for comparable stocks, (166.359). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.581). SMTI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (1.796) is also within normal values, averaging (110.838).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SMTI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
SMTI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SMTI is expected to report earnings to fall 105.15% to 17 cents per share on April 01

Sanara MedTech SMTI Stock Earnings Reports
Q4'25
Est.
$0.17
Q3'25
Missed
by $3.14
Q2'25
Beat
by $0.25
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.16
The last earnings report on November 12 showed earnings per share of -340 cents, missing the estimate of -25 cents. With 30.70K shares outstanding, the current market capitalization sits at 186.76M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
1200 Summit Avenue
Phone
+1 817 529-2300
Employees
108
Web
https://www.sanaramedtech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FANUF30.841.59
+5.44%
Fanuc Corporation
FBAK286.001.00
+0.35%
First National Bank Alaska
YGRAF0.73N/A
N/A
Yangarra Resources Ltd.
NFTM0.03N/A
N/A
The NFT Marketplace Inc.
DELKY26.50-0.50
-1.85%
Delek Group Ltd.

SMTI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SMTI has been loosely correlated with A. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SMTI jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
+1.91%
A - SMTI
47%
Loosely correlated
-1.80%
NTRA - SMTI
45%
Loosely correlated
+0.27%
MTD - SMTI
44%
Loosely correlated
-1.29%
TWST - SMTI
44%
Loosely correlated
+1.90%
IQV - SMTI
44%
Loosely correlated
-0.05%
More

Groups containing SMTI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
+1.91%
Pharmaceuticals: Other
industry (103 stocks)
38%
Loosely correlated
+0.27%
Pharmaceuticals
industry (377 stocks)
37%
Loosely correlated
+1.17%